Skip to main content
. 2021 Oct 3;24(2):245–255. doi: 10.1093/europace/euab160

Table 3.

Average time spent in each status for patients with at least one transmitted HFRS in that status

Low Medium High No record (between first and last recorded risk)
Never recorded high (N = 154)
 Total days 465.5 88.5 185.9
 Number of consecutive days to change 72.0 13.5 124.5
 IQR Proportion of Follow-up 68.4–90.5% 8.8–28.5% 0.0–0.0%

High, survived

 

(N = 236)

 Total days 367.6 259.4 54.5 135.1
 Number of consecutive days to change 37.9 25.3 13.6 123.7
 IQR proportion of follow-up 29.9–70.6% 21.7–55.1% 1.3–10.2% 0.0–0.0%

High, died

 

(N = 50)

 Total days 190.2 271.6 97.1 167.0
 Number of consecutive days to change 25.7 35.2 23.7 83.5
 IQR proportion of follow-up 1.9–51.0% 33.7–66.0% 5.3–25.6% 0.0–0.0%

All

 

(N = 440)

 Total days 384.1 201.1 61.9 147.2
 Number of consecutive days to change 48.8 22.3 15.4 122.8
 IQR proportion of follow-up 33.7–82.3% 15.1–51.1% 0.0–7.2% 0.0–0.0%

IQR, interquartile range.